retatrutide type 2 diabetes phase 2 results a1c The next installment of the triple agonist is here with more top-line 3 results. TRANSCEND-T2D-1: Retatrutide in adults with obesity and diabetes. 📉 Lowered of 1.7%–2.0% across 💉 A triple-action once-weekly injection

Tirzepatide is a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is the active ingredient in other FDA-approved drugs for the treatment of type 2 diabetes mellitus

Why it matters: Fiber is critical for gut health, regular bowel movements, and feeling satisfied

Can You Take Orlistat and Wegovy Together

The South African Health Products Regulatory Authority (SAHPRA) has warned that potentially dangerous, falsified versions of semaglutide are being marketed in the country and urged the public to only use registered products sold at licensed pharmacies

J., Kemmeries, G., Holst, J

Why Choose Tirzepatide Over Semaglutide